| Structure–Activity Relationship Studies of Pyrazolo[3,4-d]pyrimidine Derivatives Leading to the Discovery of a Novel Multikinase Inhibitor That Potently Inhibits FLT3 … LL Yang, GB Li, S Ma, C Zou, S Zhou, QZ Sun, C Cheng, X Chen, ... Journal of medicinal chemistry 56 (4), 1641-1655, 2013 | 70 | 2013 |
| Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid‐resistant from glucocorticoid‐sensitive idiopathic nephrotic syndrome patients M Lucafò, S Granata, EJ Bonten, R McCorkle, G Stocco, C Caletti, ... Clinical and translational science 14 (3), 964-975, 2021 | 24 | 2021 |
| Impact of polymorphisms in angiogenesis‐related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma WL Ma, R Liu, LH Huang, C Zou, J Huang, J Wang, SJ Chen, XG Meng, ... Clinical and Experimental Pharmacology and Physiology 44 (5), 539-548, 2017 | 24 | 2017 |
| A preclinical evaluation of a novel multikinase inhibitor, SKLB‐329, as a therapeutic agent against hepatocellular carcinoma L Zhong, XY Fu, C Zou, LL Yang, S Zhou, J Yang, Y Tang, C Cheng, LL Li, ... International journal of cancer 135 (12), 2972-2983, 2014 | 24 | 2014 |
| Genotype-guided dosing of warfarin in Chinese adults: a multicenter randomized clinical trial C Guo, Y Kuang, H Zhou, H Yuan, Q Pei, J Li, W Jiang, CM Ng, X Chen, ... Circulation: Genomic and Precision Medicine 13 (4), e002602, 2020 | 22 | 2020 |
| Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteers G Yang, R Huang, S Yang, X Zhang, X Yang, H Chen, Z Huang, C Guo, ... British Journal of Clinical Pharmacology 86 (8), 1528-1536, 2020 | 21 | 2020 |
| Design, Synthesis, and Biological Evaluation of 1‐Benzyl‐1H‐pyrazole Derivatives as Receptor Interacting Protein 1 Kinase Inhibitors C Zou, Y Xiong, LY Huang, CL Song, XA Wu, LL Li, SY Yang Chemical Biology & Drug Design 87 (4), 569-574, 2016 | 12 | 2016 |
| CpG-conjugated silver nanoparticles as a multifunctional nanomedicine to promote macrophage efferocytosis and repolarization for atherosclerosis therapy C Tang, H Wang, L Guo, C Zou, J Hu, H Zhang, W Zhou, G Yang ACS Applied Materials & Interfaces 15 (45), 52162-52179, 2023 | 11 | 2023 |
| Safety, pharmacokinetics/pharmacodynamics, and absolute bioavailability of dexmedetomidine hydrochloride nasal spray in healthy subjects: a randomized, parallel, escalating … Y Kuang, SY Wang, MN Wang, GP Yang, C Guo, S Yang, XF Zhang, ... Frontiers in Pharmacology 13, 871492, 2022 | 9 | 2022 |
| Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers S Nie, K Chen, C Guo, Q Pei, C Zou, L Yao, H Yuan, X Zhao, R Xie, X He, ... Frontiers in Pharmacology 12, 797278, 2022 | 9 | 2022 |
| Prediction of pharmacokinetic parameters of inhaled indacaterol formulation in healthy volunteers using physiologically-based pharmacokinetic (PBPK) model C Tang, CX Ou-Yang, W Chen, C Zou, J Huang, C Cui, S Yang, C Guo, ... European Journal of Pharmaceutical Sciences 168, 106055, 2022 | 9 | 2022 |
| Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration C Zou, Q Yang, S Yang, X Zhang, X Yang, Z Huang, Q Pei, J Huang, ... Pulmonary Pharmacology & Therapeutics 61, 101902, 2020 | 6 | 2020 |
| Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single‐center, open‐label phase I trial K Deng, Y Zou, C Zou, H Wang, Y Xiang, X Yang, S Yang, C Cui, G Yang, ... Cancer Medicine 12 (2), 1431-1440, 2023 | 5 | 2023 |
| Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose J Huang, W Liu, J Yu, J Yang, M Li, C Zou, C Guo, X Yang, S Yang, J Xie, ... British Journal of Clinical Pharmacology 86 (11), 2225-2233, 2020 | 5 | 2020 |
| A phase I study to evaluate the safety, tolerability, and pharmacokinetics of novel intravenous formulation of meloxicam (QP001) in healthy Chinese subjects J Ma, J Huang, C Zou, Q Wu, J Xie, X Zhang, X Yang, S Yang, Z Wu, ... Drug Design, Development and Therapy, 2303-2313, 2023 | 4 | 2023 |
| Rare ocular toxicity induced by pertuzumab/QL1209 in healthy chinese subjects: case reports and whole-exome sequencing analysis J Ma, W Chen, Z Hu, J Huang, C Guo, C Zou, G Yang Investigational New Drugs 40 (4), 861-867, 2022 | 4 | 2022 |
| Dual versus single antiplatelet therapy for patients with long-term oral anticoagulation undergoing coronary intervention: a systematic review and meta-analysis JJ Yu, C Zou, WY Liu, GP Yang Journal of Geriatric Cardiology: JGC 14 (12), 725, 2017 | 3 | 2017 |
| Tea polyphenol-derived nanomedicine for targeted photothermal thrombolysis and inflammation suppression H Wang, C Tang, Y Xiang, C Zou, J Hu, G Yang, W Zhou Journal of Nanobiotechnology 22 (1), 146, 2024 | 2 | 2024 |
| Bioavailability and safety of a new highly concentrated midazolam nasal spray compared to buccal and intravenous midazolam treatment in Chinese healthy volunteers H Wang, J Huang, S Yang, X Zhang, X Yang, C Cui, C Zou, L Li, M Zhang, ... Neurology and Therapy 11 (2), 621-632, 2022 | 2 | 2022 |
| Study on pharmacokinetic interactions between hs-10234 and emtricitabine in healthy subjects: An open-label, two-sequence, self-controlled phase I trial Y Luo, W Chen, G Yang, C Zou, J Huang, Y Kuang, K Shen, B Zhang, ... Infectious Diseases and Therapy, 1-12, 2022 | 2 | 2022 |
Guo-Bo LiSichuan UniversityПідтверджена електронна адреса в scu.edu.cn
